Response by de Ridder et al to Letter Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial"

Affiliations

¹ Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
² Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.

Comment

Inger R de Ridder et al. Stroke. 2017 Jul.

. 2017 Jul;48(7):e177.

doi: 10.1161/STROKEAHA.117.017612. Epub 2017 Jun 8.

¹ Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
² Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, the Netherlands.

No abstract available

Comment on

PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.
de Ridder IR, den Hertog HM, van Gemert HM, Schreuder AH, Ruitenberg A, Maasland EL, Saxena R, van Tuijl JH, Jansen BP, Van den Berg-Vos RM, Vermeij F, Koudstaal PJ, Kappelle LJ, Algra A, van der Worp HB, Dippel DW; Trial Organization. de Ridder IR, et al. Stroke. 2017 Apr;48(4):977-982. doi: 10.1161/STROKEAHA.116.015957. Epub 2017 Mar 13. Stroke. 2017. PMID: 28289240 Clinical Trial.
Letter by Noubiap and Kamtchum-Tatuene Regarding Article, "PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial".
Noubiap JJ, Kamtchum-Tatuene J. Noubiap JJ, et al. Stroke. 2017 Jul;48(7):e176. doi: 10.1161/STROKEAHA.117.017537. Epub 2017 Jun 8. Stroke. 2017. PMID: 28596459 No abstract available.